Carmen B. Volkart - 27 Oct 2021 Form 4 Insider Report for ANTARES PHARMA, INC.

Role
Director
Signature
/s/ Lisa M. Kallebo as attorney-in-fact for Carmen B. Volkart
Issuer symbol
N/A
Transactions as of
27 Oct 2021
Net transactions value
$0
Form type
4
Filing time
29 Oct 2021, 18:14:25 UTC
Previous filing
04 Oct 2021
Next filing
03 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRS Stock Option (right to buy) Award $0 +55,916 $0.000000 55,916 27 Oct 2021 Common Stock 55,916 $3.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.